Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Pulmonary Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06764862
What this trial is testing

Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Haisco Pharmaceutical Group Co., Ltd. 186
Testing effectiveness (Phase 2)Study completedNCT00463983
What this trial is testing

Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide

Who this might be right for
Idiopathic Pulmonary Fibrosis
Institut National de la Santé Et de la Recherche Médicale, France 25
Not applicableStudy completedNCT02229994
What this trial is testing

Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases

Who this might be right for
COPD (With - Without Rehabilitation)Diffuse Interstitial Lung DiseasesPulmonary Arterial Hypertension Primary or Secondary (Post Embolic .....)+1 more
Assistance Publique - Hôpitaux de Paris 199
Not applicableNot Yet RecruitingNCT07162870
What this trial is testing

Idiopathic Pulmonary Fibrosis Cohort of TCM

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Henan University of Traditional Chinese Medicine 1,000
Not applicableActive Not RecruitingNCT04676594
What this trial is testing

Genentech Validation Tool for Pulmonary Fibrosis

Who this might be right for
Interstitial Lung Disease
Columbia University 400
Not applicableUnknownNCT02885961
What this trial is testing

The Coagulation Cascade in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisIPFInterstitial Lung Disease
University College, London 12
Not applicableActive Not RecruitingNCT06685874
What this trial is testing

Interstitial Lung Disease Exacerbations Study

Who this might be right for
Interstitial Lung Disease (ILD)Pulmonary Fibrosis
Royal Devon and Exeter NHS Foundation Trust 1,500
Not applicableStudy completedNCT00016627
What this trial is testing

Linkage Study in Familial Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisLung DiseasesLung Diseases, Interstitial
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT07178197
What this trial is testing

Sarcopenia in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Sarcopenia
Mersin University 60
Not applicableLooking for participantsNCT00258570
What this trial is testing

Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Pulmonary Fibrosis
University of Pittsburgh 2,000
Testing effectiveness (Phase 2)WithdrawnNCT01135199
What this trial is testing

Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Stanford University
Not applicableLooking for participantsNCT07790614
What this trial is testing

Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis

Who this might be right for
IPFILDInterstitial Lung Disease (ILD)+7 more
Istituto Clinico Humanitas 156
Early research (Phase 1)Study completedNCT03502902
What this trial is testing

The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sunshine Lake Pharma Co., Ltd. 55
Not applicableStudy completedNCT00741572
What this trial is testing

Individual Sensitivity for Interstitial Lung Diseases

Who this might be right for
Interstitial Lung Diseases
Maastricht University Medical Center 100
Not applicableLooking for participantsNCT07236541
What this trial is testing

Impact of Airway Mucus Plugs on Secondary Pulmonary Fibrosis in COPD Patients: A Single-Center Case-Control Study

Who this might be right for
Lung Fibrosis
Ming Zhong 20
Not applicableNot Yet RecruitingNCT06922916
What this trial is testing

Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study

Who this might be right for
COPDInterstitial PneumoniaBronchiectasis+6 more
Zhejiang University 250
Early research (Phase 1)Study completedNCT06569381
What this trial is testing

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions

Who this might be right for
Idiopathic Pulmonary Fibrosis
Overseas Pharmaceuticals, Ltd. 18
Not applicableStudy completedNCT03281200
What this trial is testing

Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 172
Early research (Phase 1)Study completedNCT01919827
What this trial is testing

Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Clinica Universidad de Navarra, Universidad de Navarra 17
Large-scale testing (Phase 3)Study completedNCT01366209
What this trial is testing

Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genentech, Inc. 555
Next Page